State OH
Clinical Trials in Ohio
Recruiting clinical trials with at least one study location in Ohio. Data updated daily from ClinicalTrials.gov.
Top Conditions in Ohio
NCT05401097 Phase 2
Recruiting
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatm...
Condition
Acute Myeloid Leukemia
Enrollment
125 pts
Location
United States
Sponsor
Alice Mims
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
NCT05612594 Phase 4
Recruiting
Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotra...
Condition
Sleep Apnea
Enrollment
164 pts
Location
United States
Sponsor
Yale University
NCT06063122 N/A
Recruiting
Development of a Therapeutic Device to Improve Speech Sound Differentiation in P...
Condition
Premature Birth
Enrollment
203 pts
Location
United States
Sponsor
Thrive Neuromedical, LLC
NCT07226895 Phase 1, Phase 2
Recruiting
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT198...
Condition
Clinical High Risk for Psychosis (CHR)
Enrollment
150 pts
Location
United States
Sponsor
Monument Therapeutics Limited
NCT06679140 Phase 3
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolesc...
Condition
COVID-19 SARS-CoV-2 Infection
Enrollment
2,330 pts
Location
United States, Argentina, Belgium
Sponsor
Pfizer
NCT07155174 Phase 2
Recruiting
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activ...
Condition
Small Cell Lung Cancer
Enrollment
180 pts
Location
United States, Israel, Japan
Sponsor
AbbVie
NCT06528574 N/A
Recruiting
Postoperative Pain After Activation of Irrigant
Condition
Pain
Enrollment
84 pts
Location
United States
Sponsor
Cleveland Dental Institute
NCT07003542 Phase 2
Recruiting
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive ...
Condition
Glioblastoma
Enrollment
48 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT04462770 Phase 3
Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrom...
Condition
Dravet Syndrome
Enrollment
150 pts
Location
United States, Canada, Georgia
Sponsor
Epygenix
NCT05063331 N/A
Recruiting
Patient-Centered Outcomes in the Surgical Treatment of Uterovaginal Prolapse
Condition
Uterine Prolapse
Enrollment
320 pts
Location
United States
Sponsor
University Hospitals Cleveland
NCT03111459 N/A
Recruiting
Repair of Thoracoabdominal Aortic Aneurysms
Condition
Thoracoabdominal Aneurysm
Enrollment
15 pts
Location
United States
Sponsor
The Christ Hospital
NCT03118986 Phase 2
Recruiting
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Che...
Condition
Vomiting in Infants and/or Children
Enrollment
200 pts
Location
United States, Canada, India
Sponsor
The Hospital for Sick Children
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
NCT06222580 Phase 1
Recruiting
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Muta...
Condition
Acute Myeloid Leukemia With FLT3/ITD Mutation
Enrollment
30 pts
Location
United States
Sponsor
Uma Borate
NCT07154823 N/A
Recruiting
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients ...
Condition
Acute Myeloid Leukaemia (AML)
Enrollment
550 pts
Location
United States
Sponsor
Tempus AI
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT05101551 Phase 1
Recruiting
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML ...
Condition
Acute Myeloid Leukemia
Enrollment
34 pts
Location
United States
Sponsor
Norman J. Lacayo
NCT05871970 Phase 2
Recruiting
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic...
Condition
Lymphatic Malformation
Enrollment
38 pts
Location
United States
Sponsor
Protara Therapeutics
NCT06066502 Phase 3
Recruiting
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
Condition
Acute Respiratory Distress Syndrome
Enrollment
1,100 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
NCT07249346 Phase 2
Recruiting
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Rux...
Condition
Leukemia
Enrollment
124 pts
Location
United States
Sponsor
Hannah Choe, MD
NCT05587569 N/A
Recruiting
Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
Condition
Metatarsus Adductus
Enrollment
80 pts
Location
United States
Sponsor
Treace Medical Concepts, Inc.